Business Context and Reporting Period
Company: BioLife Solutions, Inc. (BLFS)
Filing Type: Form 8-K (Current Report)
Report Date: November 6, 2025
Reporting Period: Third Quarter ended September 30, 2025
Context: The Company issued a press release announcing unaudited financial results and operational highlights for the quarter.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) containing the detailed financial data. The filing text itself does not provide specific values for the following metrics:
- Revenue: Not stated in filing text.
- Profit/Loss: Not stated in filing text.
- Cash Flow: Not stated in filing text.
- Margins: Not stated in filing text.
- Debt and Liquidity: Not stated in filing text.
Material Changes
The filing text does not contain specific comparative data or descriptions of material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
The filing text does not include specific guidance, management commentary, risk factors, contingencies, or unusual items. These details are contained within the referenced press release dated November 6, 2025.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for Q3 2025.
- Verify year-over-year growth rates and margin trends in the press release.
- Check for any updated full-year 2025 guidance provided in the press release.
- Confirm the status of the Company's liquidity position and debt obligations as detailed in the unaudited results.